Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (251-260 of 378) with videos related to

Pageof 38
Sort By:
Nature Genetics|March 30, 2001
Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genesC E Glatt, J A DeYoung, S Delgado, et al.
Nature Reviews. Drug Discovery|November 1, 2007
Identifying genetic risk factors for serious adverse drug reactions: current progress and challengesRussell A Wilke, Debbie W Lin, Dan M Roden, et al.
Clinical Pharmacology and Therapeutics|August 25, 2016
A Molecular Basis for Innovation in Drug ExcipientsJ J Irwin, J Pottel, L Zou, et al.
Pharmacogenetics|May 2, 2003
Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1Douglas H Osato, Conrad C Huang, Michiko Kawamoto, et al.
Clinical Pharmacology and Therapeutics|April 22, 2018
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter ConsortiumSook Wah Yee, Deanna J Brackman, Elizabeth A Ennis, et al.
Clinical Pharmacology and Therapeutics|July 5, 2007
Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentinT J Urban, C Brown, R A Castro, et al.
Clinical Pharmacology and Therapeutics|March 7, 2014
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotypeJ P Clancy, S G Johnson, S W Yee, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 4, 2015
Prediction and validation of enzyme and transporter off-targets for metforminSook Wah Yee, Lawrence Lin, Matthew Merski, et al.
American Journal of Physiology. Renal Physiology|July 30, 2010
Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substratesJames E Shima, Takafumi Komori, Travis R Taylor, et al.
Scientific Reports|December 25, 2025
Proteomic profiling reveals age-related changes in transporter proteins in the human blood-brain barrierXujia Zhou, Mina Azimi, Niklas Handin, et al.
Pageof 38

Showing results (251-260 of 378) with videos related to

Sort By:
Pageof 38
Nature Genetics|March 30, 2001
Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genesC E Glatt, J A DeYoung, S Delgado, et al.
Nature Reviews. Drug Discovery|November 1, 2007
Identifying genetic risk factors for serious adverse drug reactions: current progress and challengesRussell A Wilke, Debbie W Lin, Dan M Roden, et al.
Clinical Pharmacology and Therapeutics|August 25, 2016
A Molecular Basis for Innovation in Drug ExcipientsJ J Irwin, J Pottel, L Zou, et al.
Pharmacogenetics|May 2, 2003
Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1Douglas H Osato, Conrad C Huang, Michiko Kawamoto, et al.
Clinical Pharmacology and Therapeutics|April 22, 2018
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter ConsortiumSook Wah Yee, Deanna J Brackman, Elizabeth A Ennis, et al.
Clinical Pharmacology and Therapeutics|July 5, 2007
Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentinT J Urban, C Brown, R A Castro, et al.
Clinical Pharmacology and Therapeutics|March 7, 2014
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotypeJ P Clancy, S G Johnson, S W Yee, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 4, 2015
Prediction and validation of enzyme and transporter off-targets for metforminSook Wah Yee, Lawrence Lin, Matthew Merski, et al.
American Journal of Physiology. Renal Physiology|July 30, 2010
Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substratesJames E Shima, Takafumi Komori, Travis R Taylor, et al.
Scientific Reports|December 25, 2025
Proteomic profiling reveals age-related changes in transporter proteins in the human blood-brain barrierXujia Zhou, Mina Azimi, Niklas Handin, et al.
Pageof 38